about
Point: Chronic Activation of the Sympathetic Nervous System is the Dominant Contributor to Systemic HypertensionChronic Kidney Disease As a Potential Indication for Renal DenervationChronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?The sympathetic nervous system alterations in human hypertensionBeyond Blood Pressure: Percutaneous Renal Denervation for the Management of Sympathetic Hyperactivity and Associated Disease StatesSympathetic nervous system overactivity and its role in the development of cardiovascular diseaseEvaluation of acepromazine-induced hemodynamic alterations and reversal with norepinephrine infusion in standing horses.Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjectsObesity as an effect modifier of the association between leptin and diabetic kidney disease.Renal denervation: intractable hypertension and beyond.Effectiveness of renal sympathetic denervation in renal function and blood pressure in CKD and non-CKD patients with controlled vs. uncontrolled hypertension.The harmful effects of subarachnoid hemorrhage on extracerebral organs.Establishment of a model of renal impairment with mild renal insufficiency associated with atrial fibrillation in canines.Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension.Determinants of cardiac autonomic dysfunction in ESRDSympathetic activation and baroreflex function during intradialytic hypertensive episodes.Depressive affect and hospitalization risk in incident hemodialysis patients.Renalase's expression and distribution in renal tissue and cellsRelationships of adrenoceptor polymorphisms with obesityRole of renal sensory nerves in physiological and pathophysiological conditionsRenal denervation prevents long-term sequelae of ischemic renal injuryCirculating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study.Heritable influence of DBH on adrenergic and renal function: twin and disease studiesChronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.Nighttime hospital blood pressure--a predictor of death, ESRD, and decline in GFROrthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study.Renal denervation suppresses atrial fibrillation in a model of renal impairment.A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD ProgressionDevice-based approaches for renal nerve ablation for hypertension and beyond.Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC StudyFiring patterns of muscle vasoconstrictor neurons in respiratory disease.Activation of afferent renal nerves modulates RVLM-projecting PVN neuronsChronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies.Renal denervation in moderate to severe CKD.N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibitionImpact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients.Renalase protects against ischemic AKIPACAP causes PAC1/VPAC2 receptor mediated hypertension and sympathoexcitation in normal and hypertensive rats.Decreased renal function is an independent predictor of severity of coronary artery disease: an application of Gensini score.
P2860
Q22306470-0BDC09B5-F560-4CE4-98AD-B46D55869EECQ26745306-2BF06571-B3E9-4D5B-80DB-8E7B3803C21AQ26748992-6288522D-B2A4-4DDB-9BF4-4B8977ABCDEFQ26863516-67639ADA-8730-48E9-A2E2-8AA1D274BC56Q28072748-D38EE0A5-6BBB-4E8C-A7BF-CC876BE2DB56Q28279754-28E71222-9571-4CBF-80B5-594D75B011FFQ30451356-C7EF0E0D-B64F-4D33-91F3-B703D523ADCFQ33556676-C647AFC6-4809-4CAA-9BFA-B3A9F0E54366Q33622272-3812A754-C425-4EA2-B906-90998BD2ADCDQ33625668-2B0E9396-65AF-4710-8312-9500A3E76E10Q33753514-285B2601-AEDB-44BB-8683-8EA1F7CD4582Q33942655-9A673B14-05C4-49EF-A3D0-DAC8F1C9E70AQ34090205-E35EC8E0-EDFE-4BFF-9A80-25F7A73D126FQ34255517-57B9CB2B-1457-4ECD-85EA-424AD95978A9Q34281387-A9C6B4D9-DB29-4AD4-9A57-C5AF9AA404F6Q34281734-DD23ADEA-FAE0-49F1-95C3-96B10612A62AQ34292832-C489998A-8AB9-41EE-ABE8-FE982D8C64E9Q34441465-85255324-6019-4E66-A67C-1E07A3600DF3Q34974804-70A977E4-1DC4-4130-88B3-19A9714643E2Q34980711-7EA0DBAD-73C8-4609-A1A8-74DFC32B385FQ35033650-F13287AB-5362-4D85-ACC7-0E249F801EE4Q35070617-C20FEE9E-9304-4873-A4DC-F556901A8282Q35082364-BE657838-C903-4C94-B44E-F3CE65A6ADA8Q35116672-9355B155-DB22-4C38-B0FA-2D777F8A7D02Q35135059-A378AD74-26CC-4BF5-BA88-CC4F99191D30Q35137813-A2E7AD45-6033-477F-A5F6-59D4330A8347Q35464440-FE8354D8-5E1A-495C-82B0-2B91D1283F7FQ35790573-0B8EA1FE-83DB-4237-AD52-A45436599D3CQ35830968-F367AA7F-9D79-45B9-97BF-38A574609F05Q35884323-94241D3A-618E-46AF-BED0-7BFCD482C156Q35913178-3956CF7D-0D9E-4BCB-8E7B-B8702370131CQ35982148-FFDE1F23-D28B-4695-93EA-B255D439BF65Q36000059-323BD2A6-A67A-4AE4-B8A5-1640ABBD816CQ36016780-787D1EBA-2A7B-49C5-9C02-BDCB0653E260Q36050927-074803F9-327E-4BEE-AA23-53BD3C3469F0Q36236587-C9B9FF1C-1CB9-4F78-93C6-2F176F667BC3Q36366261-C3D1E13D-079B-4372-BA9F-6FF32610DB85Q36638391-B378FC14-8F20-43FB-B48F-CE0FA5C18F6BQ37174587-C9A9DCEA-07F3-43EE-9821-E64053E0ED00Q37329594-5863E588-E720-44ED-8845-2E3D113E01A4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sympathetic activation in chronic renal failure.
@en
Sympathetic activation in chronic renal failure.
@nl
type
label
Sympathetic activation in chronic renal failure.
@en
Sympathetic activation in chronic renal failure.
@nl
prefLabel
Sympathetic activation in chronic renal failure.
@en
Sympathetic activation in chronic renal failure.
@nl
P2093
P356
P1476
Sympathetic activation in chronic renal failure.
@en
P2093
Flora Socratous
Gavin W Lambert
Markus P Schlaich
Murray D Esler
Nina Eikelis
Nora Straznicky
Sarah Hennebry
P304
P356
10.1681/ASN.2008040402
P577
2008-09-17T00:00:00Z